Načítá se...
Vital Signs: Pharmacy-Based Naloxone Dispensing — United States, 2012–2018
BACKGROUND: The CDC Guideline for Prescribing Opioids for Chronic Pain recommends considering prescribing naloxone when factors that increase risk for overdose are present (e.g., history of overdose or substance use disorder, opioid dosages ≥50 morphine milligram equivalents per day [high-dose], and...
Uloženo v:
| Vydáno v: | MMWR Morb Mortal Wkly Rep |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Centers for Disease Control and Prevention
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6687198/ https://ncbi.nlm.nih.gov/pubmed/31393863 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15585/mmwr.mm6831e1 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|